Sara Saberi, MD, MS
Clinical Associate Professor of Internal Medicine
Medical School
[email protected]
Available to mentor
Sara Saberi, MD, MS
Clinical Associate Professor
Manage Your Profile
Center Memberships
-
Center MemberSamuel and Jean Frankel Cardiovascular Center
Recent Publications
-
Saberi S. 2026 May 31;PresentationHypertrophic Cardiomyopathy: Emerging Paradigms in Treatment
-
Przybylski R, Norrish G, Claggett B, Ashley EA, Bhole V, Day SM, Delle Donne G, Fernandez A, Girolami F, Gray B, Helms AS, Ingles J, Kubus P, Lakdawala NK, Lampert RJ, Lin KY, Michels M, Miller E, Olivotto I, Owens A, Parikh VN, Passantino S, Radulescu CR, Rossano J, Russell MW, Ryan TD, Saberi S, Spentzou G, Stendahl JC, Ware JS, Weintraub RG, Ziolkowska L, Zwetsloot P-P, Kaski JP, Ho CY, Abrams DJ, SHaRe and IPHCC Investigators . Circulation, 2026 Apr 17;Journal ArticleThe Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.
DOI:10.1161/CIRCULATIONAHA.126.078843 PMID: 41993018 -
Floyd BJ, Njoroge JN, Krysov VA, Gomes B, Murtha R, Aribeana C, Cannie D, Smith E, Paldino A, Brown EE, Barth A, Ilhan E, Johnson R, Wojciak J, Alkhayat M, Graw S, Medo K, Haas J, Chahal CAA, Fenzl K, Steinmetz L, Gollob M, Ashley E, Day S, Judge D, Roberts JD, Vedantham V, Mao CY, Fatkin D, Lakdawala NK, Taylor MRG, Mestroni L, Saguner AM, Tayal U, Cadrin-Tourigny J, Krahn AD, James C, Dal Ferro M, Sinagra G, Merlo M, Owens A, Reza N, Saberi S, Helms A, Elliott P, Meder B, Lancaster M, Parikh VN. JAMA Cardiol, 2026 Apr 8;Journal ArticleRBM20 Truncating Variants and Human Cardiomyopathy.
DOI:10.1001/jamacardio.2026.0401 PMID: PMC13063138 -
Januzzi JL, Spertus JA, Mazimba S, Zenker MA, Bertolet BD, Wharton RH, Rawitscher DA, Kramer CM, Martinez MW, Saberi S, Setoguchi S, Masoudi FA, Chen Y-M, Memaj A, Florea V, Zhu W, Corriveau S, Hernandez AF. Journal of the American College of Cardiology, 2026 Mar 30; 87 (13): a549 - a550.Journal Article26-A-10806-ACC THE REAL-WORLD SAFETY AND EFFECTIVENESS OF MAVACAMTEN FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: INSIGHTS FROM THE US SITES OF DISCOVER-HCM REGISTRY
DOI:10.1016/j.jacc.2026.02.1480 -
Maron MS, Masri A, Olivotto I, Saberi S, Godown J, Dumitrescu C, Heitner S, Jacoby D, Kupfer S, Malik FI, Simkins TJ, Wei J, Coats C, Investigators F-HS-H. Journal of the American College of Cardiology, 2026 Mar 30; 87 (13): a589 - a590.Journal Article26-A-14402-ACC CLINICAL IMPLICATIONS ASSOCIATED WITH TEMPORARY TREATMENT INTERRUPTION AND REINITIATION OF AFICAMTEN THERAPY IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
DOI:10.1016/j.jacc.2026.02.1568 -
Masri A, Maron MS, Barriales-Villa R, Cooper RM, Elliott P, Fifer MA, Garcia-Pavia P, Owens AT, Solomon SD, Tower-Rader A, Dumitrescu C, Godown J, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Sohn R, Wei J, Saberi S. 2026 Mar 15; medRxiv,PreprintAficamten in Patients With Obstructive Hypertrophic Cardiomyopathy: An Integrated Safety Analysis
DOI:10.64898/2026.03.06.26347726 -
Vissing CR, Axelsson Raja A, Helms AS, Saberi S, Owens AT, Rossano JW, Abrams DJ, Ingles J, Gray B, Lampert R, Stendahl JC, Lakdawala NK, Ware JS, Parikh VN, Michels M, Crotti L, Ryan TD, Olivotto I, Day SM, Bundgaard H, Claggett BL, Ho CY. Circulation, 2026 Mar 9;Journal ArticleDifferences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic Cardiomyopathy.
DOI:10.1161/CIRCULATIONAHA.125.076036 PMID: 41800474 -
Tower-Rader A, Masri A, Nassif ME, Abraham TP, Barriales-Villa R, Choudhury L, Cooper RM, Elliott PM, Maron MS, Olivotto I, Oreziak A, Owens AT, Solomon SD, Heitner SB, Jacoby DL, Kupfer S, Liu X, Malik FI, Melloni C, Simkins TJ, Wei J, Saberi S. Eur Heart J, 2026 Mar 5;Journal ArticleAficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term study.
DOI:10.1093/eurheartj/ehaf1085 PMID: 41780565